Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Osmotica Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7OSMOTICA PHARM US

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLPHENIDATE HYDROCHLORIDE

    Osmotica Pharmaceuticals

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : RELEXXII

    Dosage Strength : 54MG

    Approval Date : 2022-06-23

    Application Number : 216117

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLPHENIDATE HYDROCHLORIDE

    Osmotica Pharmaceuticals

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : RELEXXII

    Dosage Strength : 36MG

    Approval Date : 2022-06-23

    Application Number : 216117

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLPHENIDATE HYDROCHLORIDE

    Osmotica Pharmaceuticals

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : RELEXXII

    Dosage Strength : 18MG

    Approval Date : 2022-06-23

    Application Number : 216117

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLPHENIDATE HYDROCHLORIDE

    Osmotica Pharmaceuticals

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : RELEXXII

    Dosage Strength : 63MG

    Approval Date : 2022-06-23

    Application Number : 216117

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLPHENIDATE HYDROCHLORIDE

    Osmotica Pharmaceuticals

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : RELEXXII

    Dosage Strength : 45MG

    Approval Date : 2022-06-23

    Application Number : 216117

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLPHENIDATE HYDROCHLORIDE

    Osmotica Pharmaceuticals

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : RELEXXII

    Dosage Strength : 27MG

    Approval Date : 2022-06-23

    Application Number : 216117

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow

    Brand Name : RELEXXII

    U.S.A
    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLPHENIDATE HYDROCHLORIDE

    Osmotica Pharmaceuticals

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : RELEXXII

    Dosage Strength : 72MG

    Approval Date : 2022-06-23

    Application Number : 216117

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.